Liu Lu, Liu Liang, Chen Lin, Chen Genqiang, Wei Yen, Hong Feng F
State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Donghua University, Shanghai, 201620, China.
College of Biological Science and Medical Engineering, Donghua University, No.2999 North Ren Min Road, Shanghai, 201620, China.
Mater Today Bio. 2024 Aug 14;28:101204. doi: 10.1016/j.mtbio.2024.101204. eCollection 2024 Oct.
The treatment of internal hemorrhage remains challenging due to the current limited antibacterial capability, hemostatic efficacy, and biocompatibility of hemostatic materials. The TEMPO-oxidized cellulose nanofibers/collagen/chitosan (TCNF/COL/CS) hemostatic aerogel was developed in this work by physically encasing COL in a sandwich structure and electrostatically self-assembling polyanionic TCNF with polycationic CS. coagulation experiments revealed the favorable procoagulant properties of TCNF/COL/CS along with high adhesion to erythrocytes and platelets. TCNF/COL/CS significantly increased the hemostatic efficacy by 59.8 % and decreased blood loss by 62.2 % in the liver injury model when compared to Surgicel®, the most frequently used hemostatic material. Furthermore, it demonstrated outstanding biodegradability both and , and a substantial increase in resistance (96.8 % against and 95.4 % against ) compared to TCNF. The significant hemostatic and biodegradable characteristics of TCNF/COL/CS can be ascribed to its interconnected porous structure, increased porosity, and efficient water absorption, along with the synergistic effect of the three constituents. The TCNF/COL/CS aerogel shows significant potential to control internal bleeding. A novel plant-derived nanocellulose composite aerogel has been described here for the first time; it has outstanding antibacterial characteristics, higher biocompatibility, and outstanding hemostatic characteristics .
由于目前止血材料的抗菌能力、止血效果和生物相容性有限,内出血的治疗仍然具有挑战性。在这项工作中,通过将胶原蛋白物理包裹在三明治结构中,并使聚阴离子的TEMPO氧化纤维素纳米纤维与聚阳离子的壳聚糖静电自组装,制备了TEMPO氧化纤维素纳米纤维/胶原蛋白/壳聚糖(TCNF/COL/CS)止血气凝胶。凝血实验表明,TCNF/COL/CS具有良好的促凝血性能,对红细胞和血小板具有高粘附性。与最常用的止血材料Surgicel®相比,在肝损伤模型中,TCNF/COL/CS显著提高了59.8%的止血效果,并减少了62.2%的失血量。此外,它在体内和体外均表现出优异的生物降解性,与TCNF相比,其耐药性大幅提高(对金黄色葡萄球菌的耐药率为96.8%,对大肠杆菌的耐药率为95.4%)。TCNF/COL/CS显著的止血和生物降解特性可归因于其相互连接的多孔结构、增加的孔隙率和高效的吸水性,以及三种成分的协同作用。TCNF/COL/CS气凝胶在控制内出血方面显示出巨大潜力。本文首次描述了一种新型植物源纳米纤维素复合气凝胶;它具有出色的抗菌特性、更高的生物相容性和出色的止血特性。